C07K 7/58
Bacitracins
Official title: Bacitracins; Related peptides
C07K7/58 (Bacitracins) appears on 13 US grants and 8 published applications in this corpus.
Search patents in C07K- Granted patents
- 13
- Published applications
- 8
- Assignees
- 14
- Inventors
- 46
- Latest grant
- 21 Sep 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for modifying microcystins and nodularins21 Sep 2021US 11,124,818 B2Cyano Biotech GmbH
- Combinational therapy for synergistic inhibition of gram-positive and gram-negative bacteria24 Sep 2019US 10,420,815 B2The Governors of the University of Alberta
- 2-amino-3-methyl-hex-5-enoic acid and its use in the production of peptides including bacitracins1 Mar 2016US 9,272,983 B2Xellia Pharmaceuticals Aps
- Bacitracin antibiotics2 Apr 2013US 8,410,044 B2Xellia Pharmaceuticals Aps
- Prevention and treatment of sepsis9 Dec 2003US 6,660,267 B1Promega Corporation
- Cyclopeptide Glass and Pharmaceutical Composition Glass Containing Cyclopeptide9 Jan 2025US 2025/0011369 A1Institute of Process Engineering, Chinese Academy of Sciences
- Processes and agents for glaucoma8 Jun 2023US 2023/0174581 A1Aufbau Medical Innovations Limited
- Bacitracin-alginate oligomer conjugates4 May 2023US 2023/0139922 A1Algipharma AS
- Method for modifying microcystins and nodularins3 Dec 2020US 2020/0377922 A1Cyano Biotech GmbH
- Combinational Therapy for Synergistic Inhibition of Gram-Positive and Gram-Negative Bacteria13 Sep 2018US 2018/0256674 A1The Governors of the University of Alberta
Most cited
By later US patents
- Conjugates for the prevention and treatment of sepsis37US 5,545,721 AOphidian Pharmaceuticals, Inc. · 1996
- Prevention and treatment of sepsis14US 6,660,267 B1Promega Corporation · 2003
- Polymyxin B conjugates8US 6,579,696 B1Promega Corporation · 2003
- Bacitracin-metal-polyether antibiotic complexes5US 4,693,992 AInternational Minerals & Chemical Corp. · 1987
- Process for the recovery of zinc bacitracin free from zinc hydroxide1US 3,937,694 APhylaxia Oltoanyag- es Tapszertermelo Vallalat · 1976